XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 127,392 $ 46,339
Short-term investments 132,643 150,917
Accounts receivable, net 17,383 11,804
Inventory 26,972 27,886
Prepaid expenses and other current assets 54,447 31,360
Total current assets 358,837 268,306
Restricted cash 743 737
Long-term investments 26,226 5,482
Property and equipment, net 82,652 85,365
Goodwill 1,931 1,931
Other intangible assets 5,120 5,265
Other assets 19,131 26,757
Total assets 494,640 393,843
Current liabilities:    
Accounts payable 7,269 6,792
Accrued expenses and other current liabilities 31,419 40,293
Senior convertible notes - current 36,224  
Liability for sale of future royalties - current 13,841 12,283
Financing liability - current 10,254 10,062
Deferred revenue — current 10,123 12,407
Total current liabilities 109,130 81,837
Liability for sale of future royalties - long term 136,913 137,362
Financing liability - long term 93,310 93,877
Deferred revenue — long term 48,194 51,160
Recognized loss on purchase commitments — long term 65,956 58,204
Operating lease liability 10,258 11,645
Milestone liabilities 2,003 2,523
Term loan 73,428  
Senior convertible notes   36,051
Total liabilities 539,192 472,659
Commitments and contingencies (Note 14)
Stockholders' deficit:    
Undesignated preferred stock, $0.01 par value - 10,000,000 shares authorized; no shares issued or outstanding as of September 30, 2025 or December 31, 2024
Common stock, $0.01 par value - 800,000,000 shares authorized; 307,027,189 and 302,959,782 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 3,070 3,029
Additional paid-in capital 3,132,249 3,118,865
Accumulated other comprehensive income 137 1,109
Accumulated deficit (3,180,008) (3,201,819)
Total stockholders' deficit (44,552) (78,816)
Total liabilities and stockholders' deficit $ 494,640 $ 393,843